ROSA-BJORKESON DAGMAR
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to ROSA-BJORKESON DAGMAR. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| XNCR | Sale | 2,503 | $20.68 | $51,762 | Sep 27, 2024 | |
| XNCR | Award / Grant | 5,986 | — | — | Jun 13, 2024 | |
| 0001270073 | Disposition | 11,625 | $19.00 | $220,875 | Nov 8, 2023 | |
| XNCR | Award / Grant | 5,007 | — | — | Jun 20, 2023 | |
| 0001270073 | Award / Grant | 8,111 | — | — | May 24, 2023 | |
| 0001270073 | Award / Grant | 7,737 | — | — | May 25, 2022 | |
| 0001270073 | Award / Grant | 10,543 | — | — | May 27, 2021 | |
| 0001567892 | Chief Strat & Corp Dev Officer | Tax Withholding | 246 | $9.06 | $2,229 | Jun 1, 2019 |
| 0001567892 | Chief Strat & Corp Dev Officer | Tax Withholding | 1,063 | $22.80 | $24,236 | Apr 1, 2019 |
| 0001567892 | Chief Strat & Corp Dev Officer | Tax Withholding | 247 | $17.05 | $4,211 | Jun 1, 2018 |
| 0001620546 | EVP and President, Biosimilars | Disposition | 71,293 | — | — | Jun 3, 2016 |
| 0001620546 | EVP and President, Biosimilars | Tax Withholding | 982 | $39.30 | $38,593 | Mar 3, 2016 |
| 0001620546 | EVP and President, Biosimilars | Tax Withholding | 6,893 | $34.63 | $238,705 | Dec 1, 2015 |
| 0001620546 | EVP and President, Biosimilars | Tax Withholding | 6,893 | $34.63 | $238,705 | Dec 1, 2015 |
| 0001620546 | See Remarks | Other | 62,869 | — | — | Jul 1, 2015 |